Compared to other techniques, Intravascular Ultrasound (IVUS) is much better at monitoring the increase or decrease of atherosclerosis in the coronary arteries. Can the method even be used to predict the odds of a heart attack or other cardiovascular event?
Studies indicate this may be the case, states Professor Clemens von Birgelen in his inaugural address at the University of Twente. Results of IVUS measurements also raise the question of whether patients with demonstrated coronary disease should be treated with more powerful cholesterol-lowering statins to reverse atherosclerosis. Von Birgelen's inaugural address takes place on 5 June.
Narrowed coronary arteries due to atherosclerosis can be visualised using 'classic' cardiac catheterisation, but the technique only shows the space the blood flows through, the 'lumen', and not the diseased vascular wall surrounding it. By using a specialised catheter with an ultrasound 'sensor', IVUS also creates images of the calcifications, the ‘plaque’, and allows various components of the plaque to be identified – not only calcium, but also fat and connective tissue.
Von Birgelen states that this additional information is important for assessing disease progression - plaque progression. Plaque initially leaves the lumen unaffected and grows outward. The blood vessel as a whole becomes wider, leading to a significantly increased risk of heart attack. However, plaques may also decrease in volume while the lumen diameter remains the same, something that can only be determined using IVUS.
Various studies have shown a relationship between plaque growth and cardiovascular events, such as heart attacks. “Plaque progression measured using IVUS could become a valuable 'surrogate marker' for cardiovascular events”, states Von Birgelen. In his address, he also highlights the relationship between plaque progression and cholesterol. Decreasing cholesterol through intensive statin therapy not only slows plaque formation, but actually reverses it. This is reason enough for the professor to question the current target value for LDL cholesterol of 2.5 for patients with coronary disease; at that value, over half of patients still have plaque growth. Von Birgelen wants to determine whether or not a large group of patients is receiving sub-optimal treatment for reducing plaque.
Drug eluting stents
IVUS also plays an important role in the treatment of narrow coronary arteries, for example during balloon dilation and the placement of a so-called 'stent'. New types of stents are being made with integrated regulated drug release to prevent the formation of scar tissue in the stent – thereby decreasing the odds of recurrence. Von Birgelen is currently performing research on these new stents at the University of Twente, and will soon be launching the so-called 'TWENTE study' at the Medisch Spectrum Twente hospital, in which about 1400 patients will be treated with one of two promising drug eluting stents in order to compare the clinical results. “During some PCI procedures, IVUS is essential for properly guiding the implantation”, according to Von Birgelen. He believes that good invasive imaging of the coronary arteries will remain important in future in order to safeguard the quality of care for heart patients.
Professor Clemens von Birgelen is a cardiologist on staff at the Thorax Centre of the Medisch Spectrum Twente in Enschede. His Chair at the University of Twente, made possible in part by the Heart Centre Twente Foundation and entrepreneur Ferdinand Fransen, shares the university's ambition to play a leading role in the development and application of technology in healthcare.
Wiebe van der Veen | alfa
Novel chip-based gene expression tool analyzes RNA quickly and accurately
18.01.2018 | University of Illinois College of Engineering
Potentially life-saving health monitor technology designed by Sussex University physicists
10.01.2018 | University of Sussex
On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.
We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...
What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...
For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.
Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...
At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.
No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...
Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.
Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...
08.01.2018 | Event News
11.12.2017 | Event News
08.12.2017 | Event News
22.01.2018 | Life Sciences
22.01.2018 | Power and Electrical Engineering
22.01.2018 | Power and Electrical Engineering